Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
EEF1A2
REST API REST API
Homo sapiens
EEF1A2 is differentially expressed in 242 experiments: 159 organism parts: liver, lung, ... (157 more);, 201 disease states: normal, prostate carcinoma, ... (199 more);, 65 cell types 518 cell lines 30 compound treatments and 60 other conditions.
Synonyms HS1, STN, EEF1AL, STNL
Orthologs EEF1A2 (Danio rerio)   TEF2 (Saccharomyces cerevisiae)   TEF1 (Saccharomyces cerevisiae)   F1N9H4_CHICK (Gallus gallus)   Eef1a2 (Mus musculus)   EF1A2_BOVIN (Bos taurus)   Eef1a2 (Rattus norvegicus)   eef1a2 (Xenopus laevis)   EEF1A2 (Canis familiaris)   (Compare orthologs)
Gene Ontology Term eukaryotic translation elongation factor 1 complex, GTPase activity, protein binding, cytoplasm, translation elongation factor activity, translational elongation, translation, anti-apoptosis, GTP binding, translation factor activity, nucleic acid binding, nucleus, nucleotide binding, neuronal cell body, response to inorganic substance
InterPro Term Transl_elong_EFTu/EF1A_2, Transl_elong_EFTu/EF1A_C, Transl_elong_EF1A_euk/arc, ProtSyn_GTP-bd
UniProt Accession Q05639
Search EB-eye ENSG00000101210
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-803, E-GEOD-15765, E-AFMX-5, E-MTAB-24, E-MTAB-25, ... (21 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-3860, E-GEOD-17482, E-GEOD-5258, E-GEOD-4525, E-GEOD-19639, ... (47 experiments)

Factor Value U/D Experiments
HT1080
2
E-MTAB-37, E-GEOD-20089
A549
2
E-GEOD-6013, E-GEOD-3202
AGS
2
E-MTAB-37, E-GEOD-15460
BT20
2
E-MTAB-37, E-MTAB-62
HCC2157
2
E-MTAB-37, E-MTAB-62
LNCaP
2
E-GEOD-14990, E-GEOD-14464
512 more value(s).


Cell type

studied in E-GEOD-20193, E-GEOD-21668, E-GEOD-19397, E-GEOD-3920, E-GEOD-4219, ... (36 experiments)

Factor Value U/D Experiments
primary human mammary epithelial cells
1
E-GEOD-29119
keratinocyte
1
E-GEOD-3204
macrophage
1
E-GEOD-8286
CD34+Thy+ hematopoietic stem cell
1
1
E-GEOD-96
leydig cell
1
E-MTAB-25
LCC
1
E-GEOD-19188
59 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-1615, E-GEOD-2466, E-MEXP-1121, E-MEXP-2280, ... (51 experiments)

Factor Value U/D Experiments
prostate carcinoma
4
E-MEXP-2034, E-MTAB-62, E-GEOD-3868, E-MTAB-37
Burkitt's lymphoma
3
E-MTAB-37, E-GEOD-1880, E-GEOD-96
Huntington's disease
2
E-AFMX-6, E-GEOD-3790
chronic lymphocytic leukemia
2
E-GEOD-2466, E-MTAB-37
colon carcinoma
2
E-GEOD-3726, E-MTAB-62
juvenile dermatomyositis
2
E-MTAB-62, E-GEOD-3307
195 more value(s).


Compound treatment

studied in E-GEOD-1615, E-GEOD-571, E-GEOD-5824, E-GEOD-5099, E-GEOD-6462, ... (19 experiments)

Factor Value U/D Experiments
valproic acid
1
E-GEOD-1615
keratinocyte growth factor
1
E-GEOD-7216
FCCP
1
E-MEXP-2285
sapphyrin PCI-2050
1
E-GEOD-6400
rapamycin
1
E-GEOD-5824
bacterial endotoxin
1
E-GEOD-3284
24 more value(s).


Biopsy tissue

studied in E-GEOD-5851

Factor Value U/D Experiments
bone
1
E-GEOD-5851


Biosource provider
studied in E-MTAB-37

BioSourceProvider
studied in E-GEOD-19519, E-GEOD-19480

Blood/non-blood meta-groups
studied in E-MTAB-62

Bmngrd
studied in E-GEOD-20194, E-GEOD-16716

Cell treatment
studied in E-MEXP-1192

Cellular component
studied in E-GEOD-1400

Clinical history
studied in E-GEOD-22097, E-GEOD-19420, E-GEOD-19743, E-GEOD-21589, E-GEOD-16363, ... (6 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-6710, E-GEOD-2191, E-GEOD-2034, ... (7 experiments)

Clinical treatment
studied in E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-GEOD-19743, E-GEOD-1614, E-GEOD-20033, E-GEOD-3140, E-GEOD-4667, ... (7 experiments)

Disease staging
studied in E-GEOD-1323, E-GEOD-19743, E-GEOD-3325, E-TABM-147, E-GEOD-3013 ... (5 experiments)

Environmental stress
studied in E-GEOD-1643

Er ihc
studied in E-GEOD-21653

Estrogen receptor status
studied in E-GEOD-4922, E-GEOD-20194, E-GEOD-16716

Ethnic group
studied in E-GEOD-20194, E-GEOD-16716

Genetic modification
studied in E-GEOD-8023, E-GEOD-7011, E-MEXP-1482, E-GEOD-7578, E-GEOD-20847, ... (7 experiments)

Genotype
studied in E-MEXP-1996, E-GEOD-2466, E-MEXP-421, E-GEOD-2292, E-TABM-868, ... (9 experiments)

Gestation age
studied in E-GEOD-14334

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-TABM-263, E-GEOD-5681, E-GEOD-12773, E-GEOD-20504, E-MEXP-1446, ... (7 experiments)

Her2 fish
studied in E-GEOD-20194, E-GEOD-16716

Her2 ihc
studied in E-GEOD-20194, E-GEOD-16716

Histology
studied in E-TABM-234, E-TABM-276, E-GEOD-20194, E-GEOD-16716

Individual
studied in E-MTAB-197, E-GEOD-2466, E-GEOD-1926, E-MEXP-2069, E-GEOD-20876, ... (28 experiments)

Infection
studied in E-GEOD-12108, E-MEXP-561

Karyotype
studied in E-GEOD-12662

Labeling
studied in E-LGCL-5

Light
studied in E-GEOD-1725

Material type
studied in E-MEXP-455

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

organ
studied in E-GEOD-24283

Organism
studied in E-GEOD-7540, E-GEOD-1801, E-GEOD-426

Organism status
studied in E-GEOD-19188

Phenotype
studied in E-GEOD-1309, E-GEOD-21750, E-GEOD-1657, E-GEOD-3407

Population
studied in E-GEOD-4922

Progesterone receptor status
studied in E-GEOD-6532

Progression free survival of days
studied in E-GEOD-5851

Protocol type
studied in E-GEOD-22097, E-GEOD-3254, E-GEOD-19445, E-GEOD-19246

Qpcr egfr dct
studied in E-GEOD-5851

RNAi
studied in E-GEOD-1703, E-MEXP-1509, E-GEOD-1676, E-MEXP-101, E-GEOD-3697, ... (6 experiments)

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-19743, E-GEOD-21374, E-MEXP-70, E-GEOD-17400

Sex
studied in E-GEOD-2466

Strain or line
studied in E-MEXP-1996, E-TABM-125

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-19188

targeted_cell_type
studied in E-MEXP-70

Test result
studied in E-GEOD-1926, E-TABM-276, E-GEOD-2748

Treatment
studied in E-GEOD-16837, E-GEOD-19246, E-GEOD-13818, E-GEOD-19815, E-GEOD-12198 ... (5 experiments)

Treatment code
studied in E-GEOD-20194, E-GEOD-16716

Tumor grading
studied in E-GEOD-1561, E-TABM-147

Vehicle
studied in E-GEOD-5258

Processing time: 0.27 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM